Pharma Two B ^{For Profit}

Pharma Two B is a pharmaceutical company that develops innovative combination products based on previously approved drugs with a favorable balance between safety and efficacy. They aim to improve patients' quality of life. The company's main focus is on the treatment of Parkinson's disease. They have developed a novel, once-daily combination of extended-release pramipexole and rasagiline, called P2B001, specifically for the treatment of Parkinson's disease. The company has completed Phase III clinical studies for P2B001, demonstrating improved motor symptoms and daily function, good tolerability, and safety. Contact info: N/A.